Skip to main content
. Author manuscript; available in PMC: 2013 Dec 17.
Published in final edited form as: J Peripher Nerv Syst. 2009 Sep;14(3):10.1111/j.1529-8027.2009.00230.x. doi: 10.1111/j.1529-8027.2009.00230.x

Table 2.

Assessment of neuropathy: results from the neurological examinations, nerve conduction studies, and composite total neuropathy score.

Mean scores (SD) Subjects (n = 37) Population norms
Neuropathy impairment score (NIS) 3.0 (3.6) 0
Nerve conduction studies (NCS)
Peroneal nerve CMAP amplitude (mV) 3.8 (2.0) 9.5 (3.7)
Sural nerve SNAP amplitude (µV) 16.1 (9.9) 14.4 (7.0)
Median nerve CMAP amplitude (mV)* 10.1 (3.6) 13.2 (4.1)
Median nerve SNAP amplitude (µV) 36.8 (18.4) 25.7 (8.9)
Total neuropathy score reduced (TNSr) 4.0 (2.0)

CMAP, compound muscle action potential; SNAP, sensory nerve action potential.

*

One child refused median nerve CMAP.

Two children refused median nerve SNAP.